Yang, Katherine S.
O’Shea, Aileen
Zelga, Piotr
Liss, Andrew S.
Del Castillo, Carlos Fernandez
Weissleder, Ralph
Funding for this research was provided by:
National Cancer Institute (R01CA237332)
Article History
Received: 17 April 2023
Accepted: 30 June 2023
First Online: 6 July 2023
Competing interests
: RW is a consultant to ModeRNA, Lumicell, Seer Biosciences, Earli, and Accure Health, none of whom contributed to this research. The other authors have no competing interest.